Sino Biopharmaceutical

health

GSK Taps Local Giant SBP to Market Hepatitis B Drug in China

GSK partners with Sino Biopharmaceutical subsidiary CTTQ to sell its experimental chronic hepatitis B therapy bepirovirsen across China.